Annual Drug Patent Expirations for KATERZIA
Katerzia is a drug marketed by Azurity and is included in one NDA. It is available from one supplier. There are nine patents protecting this drug.
This drug has ten patent family members in six countries.
The generic ingredient in KATERZIA is amlodipine benzoate. One supplier is listed for this compound. Additional details are available on the amlodipine benzoate profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
